RxDoctor Payments Data

Stephen Hass, MD

Vascular Surgery · Charleston, WVNPI 1275757742

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,647 of the $3,049 with a category attached, or 86.8%. 19 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 30.8% of the total. Reporting peaked in 2019 at $1,168 and has fallen 72.3% since, to $323 in 2025. That places this record below the midpoint for vascular surgery clinicians in WV, where the typical reported total is $5,101.

$3,049in general payments, 2019–2025

Across 78 payments — averaging $39.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$939
  • Bard Peripheral Vascular, Inc.$533
  • Silk Road Medical, Inc.$353
  • Boston Scientific$294
  • Abbott$205
  • Genentech USA, Inc.$133
  • plus $592 from 13 others
$34,081in research payments, 2019–2025

Across 31 payments — averaging $1099.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • W. L. Gore & Associates, Inc.$34K

What the payments were for

  • Travel & lodging$40213%
  • Food & beverage$2,64787%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,049 in reported general payments places this provider in the 40th percentile of 32 vascular surgery providers in West Virginia.

See all vascular surgery providers in West Virginia

Medicare billing

Part B allowed, 2024
$68,435
Medicare patients
470
Services billed
851

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Warfarin Sodium17$328
ClopidogrelClopidogrel Bisulfate30$312
Tramadol Hcl26$195
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$59

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →